Research Article
Serum HMGB1 as a Potential Biomarker for Patients with Asbestos-Related Diseases
Table 4
Relationship between HMGB1 and MMPs covariates in study groups.
| Group | Coefficient | (HMGB1, MMP2) | (HMGB1, MMP9) | (MMP2, MMP9) |
| Healthy | | 0.1998 | 0.2580 | 0.586 | | 0.0949 | 0.0298 | <0.001 | AE < 10 Y | | 0.2215 | 0.2721 | 0.345 | | 0.0037 | 0.0003 | <0.001 | AE ≥ 10 Y | | 0.2345 | 0.1456 | 0.269 | | 0.0075 | 0.0997 | 0.002 | PP | | 0.0677 | 0.0099 | 0.494 | | 0.5483 | 0.9303 | <0.001 | Asbestosis | | −0.0343 | −0.1347 | 0.018 | | 0.8548 | 0.4701 | 0.925 | MPM | | 0.0821 | 0.3464 | 0.725 | | 0.7710 | 0.2059 | 0.002 |
|
|
AE: asbestos-exposed; PP: pleural plaques; Y: years; : Spearman’s rank correlation coefficient.
|